Fortis Malar Hospitals Ltd
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of providing health care & medical services[1]
- Market Cap ₹ 99.2 Cr.
- Current Price ₹ 53.0
- High / Low ₹ 108 / 44.0
- Stock P/E
- Book Value ₹ 15.8
- Dividend Yield 80.3 %
- ROCE -1.54 %
- ROE -6.99 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is providing a good dividend yield of 80.3%.
Cons
- Stock is trading at 3.35 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -16.4% over past five years.
- Company has a low return on equity of -12.6% over last 3 years.
- Earnings include an other income of Rs.64.3 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98 | 108 | 118 | 130 | 141 | 149 | 145 | 112 | 69 | 86 | 86 | 59 | 23 | |
86 | 99 | 110 | 123 | 140 | 147 | 147 | 115 | 76 | 83 | 81 | 60 | 25 | |
Operating Profit | 11 | 9 | 8 | 6 | 1 | 2 | -2 | -3 | -6 | 3 | 5 | -1 | -2 |
OPM % | 12% | 8% | 6% | 5% | 1% | 1% | -2% | -2% | -9% | 4% | 5% | -2% | -8% |
46 | 7 | 7 | 7 | 8 | 8 | 10 | 11 | 15 | 7 | 7 | 67 | 64 | |
Interest | -2 | 0 | 1 | 0 | 0 | 0 | 1 | 8 | 7 | 7 | 6 | 4 | 2 |
Depreciation | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 13 | 13 | 13 | 12 | 9 | 4 |
Profit before tax | 56 | 13 | 12 | 10 | 4 | 5 | 2 | -12 | -11 | -8 | -7 | 52 | 57 |
Tax % | 24% | 34% | 34% | 36% | 30% | 41% | 27% | -26% | -30% | 0% | 119% | 9% | |
43 | 9 | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -16 | 47 | 52 | |
EPS in Rs | 23.22 | 4.60 | 4.12 | 3.35 | 1.51 | 1.68 | 0.93 | -4.83 | -4.27 | -4.43 | -8.29 | 25.23 | 27.78 |
Dividend Payout % | 0% | 11% | 12% | 15% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 169% |
Compounded Sales Growth | |
---|---|
10 Years: | -6% |
5 Years: | -16% |
3 Years: | -5% |
TTM: | -71% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 17% |
TTM: | 89% |
Stock Price CAGR | |
---|---|
10 Years: | 4% |
5 Years: | 1% |
3 Years: | -6% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | -3% |
5 Years: | -13% |
3 Years: | -13% |
Last Year: | -7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
Reserves | 58 | 66 | 72 | 78 | 80 | 83 | 85 | 76 | 68 | 59 | 43 | 90 | 11 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 64 | 57 | 53 | 46 | 0 | 0 | |
13 | 16 | 19 | 32 | 31 | 46 | 45 | 33 | 23 | 27 | 27 | 6 | 7 | |
Total Liabilities | 90 | 101 | 110 | 129 | 129 | 147 | 148 | 191 | 167 | 159 | 136 | 115 | 36 |
17 | 18 | 18 | 24 | 25 | 24 | 22 | 81 | 69 | 58 | 47 | 0 | 0 | |
CWIP | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
72 | 82 | 92 | 104 | 104 | 123 | 126 | 110 | 98 | 101 | 88 | 115 | 36 | |
Total Assets | 90 | 101 | 110 | 129 | 129 | 147 | 148 | 191 | 167 | 159 | 136 | 115 | 36 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-64 | 6 | 4 | 11 | -10 | 10 | -16 | -0 | -1 | 7 | 6 | -7 | |
72 | -1 | 5 | -22 | 15 | -2 | 6 | 48 | -28 | 8 | 0 | 120 | |
-7 | -1 | 0 | -1 | -1 | 0 | 0 | -12 | -7 | -10 | -13 | -11 | |
Net Cash Flow | 2 | 3 | 9 | -12 | 4 | 8 | -9 | 36 | -36 | 5 | -7 | 102 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12 | 13 | 13 | 17 | 14 | 15 | 24 | 12 | 11 | 9 | 14 | 0 |
Inventory Days | 4 | 13 | 35 | 28 | 22 | 18 | 22 | 42 | 40 | 32 | 0 | |
Days Payable | 153 | 169 | 286 | 173 | 276 | 255 | 323 | 375 | 429 | 584 | ||
Cash Conversion Cycle | 12 | -136 | -143 | -234 | -130 | -239 | -212 | -289 | -322 | -379 | -539 | 0 |
Working Capital Days | 213 | 189 | 166 | 127 | 150 | 130 | 154 | -38 | 134 | 52 | 219 | 4 |
ROCE % | 17% | 17% | 14% | 12% | 5% | 6% | 3% | -3% | -7% | -1% | -1% | -2% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Nov
-
Outcome Of Board Meeting In Accordance With The SEBI (LODR) Regulations, 2015.
5 Nov - Approval of financial results and key appointments.
-
Appointment of Company Secretary and Compliance Officer
5 Nov - Approval of financial results and key management appointments.
-
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With The SEBI (LODR) Regulations, 2015.
5 Nov - Approval of financial results and key appointments.
-
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (LODR) Regulations, 2015.
28 Oct - Notice of Board Meeting to approve financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is a part of Fortis Group, being subsidiary of Fortis Hospitals Limited and Intermediate Holding Company of Fortis Healthcare Ltd. The Hospital building is owned by a fellow subsidiary, Fortis Health Management Limited. Company has entered into Hospital and Medical Services Agreement
with FHML for rendering of medical and healthcare services at the hospital building